Laboratorios Farmaceuticos Rovi (ROVIN) Q3 2026 Earnings Report
MX:ROVIN Q3 2026 EPS Results
- Actual EPS
- ―
- Consensus EPS
- ―
- Beat/Miss
- ―
- One Year Ago EPS
- MXN 23.68
MX:ROVIN Q3 2026 Revenue Results
- Actual Revenue
- ―
- Expected Revenue
- MXN 4.89B
- Beat/Miss
- ―
- YoY Revenue Growth
- ―
Earnings Announcement Details
- Quarter
- Q3 2026
- Date
- 11/05/2026
- Time
- Before Open
- Conference Call
- Thursday, November 5, 2026
MX:ROVIN Upcoming Earnings
Laboratorios Farmaceuticos Rovi's next earnings date is estimated for February 24, 2027, based on past reporting schedules.
Q3 2026 Earnings Call Audio
No earnings call audio is available for this earnings event.
Q3 2026 Earnings Slide Deck
No slide deck is available for this earnings event.
Q3 2026 Earnings Call Summary
No earnings call summary is available for this earnings event.
MX:ROVIN Earnings History
| Report Date | Fiscal Quarter | Forecast / EPS | Last Year's EPS | EPS YoY Change | Press Release |
|---|---|---|---|---|---|
| Feb 24, 2027 | 2026 (Q4) | ―- | 17.42 | ― | ― |
| Nov 05, 2026 | 2026 (Q3) | ―- | 23.68 | ― | |
| Jul 23, 2026 | 2026 (Q2) | ―30.62 | 8.83 | 246.57% (+21.78) | |
| May 06, 2026 | 2026 (Q1) | ―3.86 | 7.39 | -47.74% (-3.53) | |
| Feb 25, 2026 | 2025 (Q4) | ―17.42 | 9.54 | 82.49% (+7.87) | |
| Nov 06, 2025 | 2025 (Q3) | ―23.68 | 17.96 | 31.86% (+5.72) | |
| Jul 24, 2025 | 2025 (Q2) | ―8.83 | 17.96 | -50.81% (-9.13) | |
| May 08, 2025 | 2025 (Q1) | ―7.39 | 6.04 | 22.49% (+1.36) | |
| Feb 25, 2025 | 2024 (Q4) | ―9.54 | 20.76 | -54.02% (-11.21) | |
| Nov 07, 2024 | 2024 (Q3) | ―28.49 | 20.42 | 39.47% (+8.06) |
The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.
Beat Missed
